GPT and type 2 diabetes mellitus: There were also correlations between SomaSignal prediction probabilities for MASH ballooning and AST and ALT at baseline that were greater in participants with T2D (STEP 2) than in those without (STEP 1) (0.41 [95% CI 0.38–0.44] and 0.37 [95% CI 0.33–0.40] vs. 0.20 [95% CI 0.18–0.23] and 0.20 [95% CI 0.17–0.22], respectively) (Fig. S3).